Angle plc (AGL) Ordinary 10p
- Add to watchlist
- Create an alert
- This stock can be held in a
12.25p
13.18p
31.40p
£33.88 million
12.25p
12.00p
9.13p
n/a
0.50p (3.92%) Previous:
0.50p
714,579
n/a
15,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue (£m) | 1.04 | 1.01 |
Profit before tax (£m) | (24.44) | (17.36) |
Adjusted EPS (p): | (8.97) | (6.67) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Angle receives 'breakthrough results' from DNA molecular analysis
4 January 2024 07:58
-
Angle locks in $250,000 contract with Eisai
2 January 2024 09:04
-
Angle losses widen in 'breakthrough year'
21 April 2023 11:06
-
Standard form for notification of major holdings
10 January 2024 12:57
-
Breakthrough clinical results
4 January 2024 07:00
-
Contract announcement with Eisai Inc.
2 January 2024 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.